☰

Zhanna Sobol, Ph.D. - Publications

Affiliations: 
2007 University of California, Los Angeles, Los Angeles, CA 
Area:
Toxicology
Tree Info Similar researchers PubMed Report error

7/17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Guha M, Sobol Z, Martin M, Hemkens M, Sung T, Rubitski E, Spellman R, Finkelstein M, Khan N, Hu W. Comparative Analyses of Poly(ADP-Ribose) Polymerase Inhibitors. International Journal of Toxicology. 10915818221121325. PMID 35989659 DOI: 10.1177/10915818221121325  0.304
2016 Berman CL, Barros SA, Galloway SM, Kasper P, Oleson FB, Priestley CC, Sweder KS, Schlosser MJ, Sobol Z. OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based Therapeutics. Nucleic Acid Therapeutics. 26: 73-85. PMID 26978711 DOI: 10.1089/nat.2015.0534  0.359
2012 Sobol Z, Schiestl RH. Intracellular and extracellular factors influencing Cr(VI) and Cr(III) genotoxicity. Environmental and Molecular Mutagenesis. 53: 94-100. PMID 22020802 DOI: 10.1002/Em.20679  0.549
2009 Reliene R, Pollard JM, Sobol Z, Trouiller B, Gatti RA, Schiestl RH. N-acetyl cysteine protects against ionizing radiation-induced DNA damage but not against cell killing in yeast and mammals. Mutation Research. 665: 37-43. PMID 19427509 DOI: 10.1016/J.Mrfmmm.2009.02.016  0.606
2008 Sobol Z, Cook NM, Schiestl RH. HNO induces DNA deletions in the yeast S. cerevisiae. Mutation Research. 638: 83-9. PMID 17963796 DOI: 10.1016/J.Mrfmmm.2007.08.018  0.627
2008 Rodriguez CE, Sobol Z, Schiestl RH. 9,10-Phenanthrenequinone induces DNA deletions and forward mutations via oxidative mechanisms in the yeast Saccharomyces cerevisiae. Toxicology in Vitro : An International Journal Published in Association With Bibra. 22: 296-300. PMID 17959352 DOI: 10.1016/J.Tiv.2007.09.001  0.61
2007 Sobol Z, Engel ME, Rubitski E, Ku WW, Aubrecht J, Schiestl RH. Genotoxicity profiles of common alkyl halides and esters with alkylating activity. Mutation Research. 633: 80-94. PMID 17644026 DOI: 10.1016/J.Mrgentox.2007.05.004  0.478
Low-probability matches (unlikely to be authored by this person)
2015 Greene N, Dobo KL, Kenyon MO, Cheung J, Munzner J, Sobol Z, Sluggett G, Zelesky T, Sutter A, Wichard J. A practical application of two in silico systems for identification of potentially mutagenic impurities. Regulatory Toxicology and Pharmacology : Rtp. 72: 335-49. PMID 25980641 DOI: 10.1016/j.yrtph.2015.05.008  0.27
2023 Bercu JP, Zhang S, Sobol Z, Escobar PA, Van P, Schuler M. Comparison of the transgenic rodent mutation assay, error corrected next generation duplex sequencing, and the alkaline comet assay to detect dose-related mutations following exposure to N-nitrosodiethylamine. Mutation Research. Genetic Toxicology and Environmental Mutagenesis. 891: 503685. PMID 37770142 DOI: 10.1016/j.mrgentox.2023.503685  0.25
2014 Mailhol D, Willwacher J, Kausch-Busies N, Rubitski EE, Sobol Z, Schuler M, Lam MH, Musto S, Loganzo F, Maderna A, Fürstner A. Synthesis, molecular editing, and biological assessment of the potent cytotoxin leiodermatolide. Journal of the American Chemical Society. 136: 15719-29. PMID 25347620 DOI: 10.1021/Ja508846G  0.208
2014 Sobol Z, Spellman RA, Thiffeault C, Dobo KL, Schuler M. Impact of cell cycle delay on micronucleus frequency in TK6 cells. Environmental and Molecular Mutagenesis. 55: 64-9. PMID 23982927 DOI: 10.1002/em.21810  0.18
2012 Sobol Z, Homiski ML, Dickinson DA, Spellman RA, Li D, Scott A, Cheung JR, Coffing SL, Munzner JB, Sanok KE, Gunther WC, Dobo KL, Schuler M. Development and validation of an in vitro micronucleus assay platform in TK6 cells. Mutation Research. 746: 29-34. PMID 22445949 DOI: 10.1016/j.mrgentox.2012.02.005  0.154
2016 Thybaud V, Kasper P, Sobol Z, Elhajouji A, Fellows M, Guerard M, Lynch AM, Sutter A, Tanir JY. Genotoxicity assessment of peptide/protein-related biotherapeutics: points to consider before testing. Mutagenesis. PMID 27000792 DOI: 10.1093/mutage/gew013  0.126
2021 Drewe WC, Dobo KL, Sobol Z, Bercu JP, Parris P, Nicolette J. Deriving Compound-Specific Exposure Limits for Chemicals Used in Pharmaceutical Synthesis: Challenges in Expert Decision-Making Exemplified Through a Case Study-Based Workshop. International Journal of Toxicology. 1091581820982547. PMID 33525949 DOI: 10.1177/1091581820982547  0.11
2022 Bowman CJ, Becourt-Lhote N, Boulifard V, Cordts R, Corriol-Rohou S, Enright B, Erkman L, Harris J, Hartmann A, Hilpert J, Kervyn S, Mattson B, Morford L, Muller M, Powell M, ... Sobol Z, et al. Science-Based Approach to Harmonize Contraception Recommendations in Clinical Trials and Pharmaceutical Labels. Clinical Pharmacology and Therapeutics. PMID 35388453 DOI: 10.1002/cpt.2602  0.108
2011 Mascitti V, Maurer TS, Robinson RP, Bian J, Boustany-Kari CM, Brandt T, Collman BM, Kalgutkar AS, Klenotic MK, Leininger MT, Lowe A, Maguire RJ, Masterson VM, Miao Z, Mukaiyama E, ... ... Sobol Z, et al. Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors. Journal of Medicinal Chemistry. 54: 2952-60. PMID 21449606 DOI: 10.1021/jm200049r  0.076
2020 Zane D, Feldman PL, Sawyer T, Sobol Z, Hawes J. Development and Regulatory Challenges for Peptide Therapeutics. International Journal of Toxicology. 1091581820977846. PMID 33327828 DOI: 10.1177/1091581820977846  0.042
Hide low-probability matches.